AI Tool Comparison

Comparing as AI Medical Research & Clinical Decision Support
Schrödinger vs Tempus AI

VS
Schrödinger official logo and brand icon

Schrödinger

Enterprise
Tempus AI official logo and brand icon

Tempus AI

Enterprise

Verdict by Category

Detailed category analysis is not available for this comparison.
Feature & Spec Matrix

Detailed Comparison26 Criteria

Complete side-by-side breakdown of specifications, capabilities, and feature parity

Swipe horizontally to compare features
Feature / Spec
Schrödinger
Schrödinger
Tempus AI
Tempus AI
Pricing Model
EnterprisePhysics-based molecular modeling & drug discovery suite — Academic site licenses & commercial enterprise quotes on sales consultation
EnterpriseGenomic sequencing, clinical data analytics, and precision medicine AI — Custom institutional agreements for healthcare systems and life sciences
Starting Price
Custom / Contact Sales
Custom / Contact Sales
Free Plan & Trial Scope
Difference
Academic licensing available at reduced rates; commercial pricing via sales team
No free plan — genomic tests ordered by physicians; enterprise and biopharma data partnerships via sales
User Rating Score
Unrated
Unrated
Ideal Workflow / Use Case
Difference
Pharmaceutical scientists and computational chemists needing physics-based molecular simulation for drug discovery, lead optimization, and ADMET prediction
Oncologists, health systems, and biopharma companies needing AI-powered genomic profiling, precision medicine insights, clinical trial matching, and drug development data
Enterprise & Scalability
Difference
NASDAQ listed (SDGR), enterprise software licensing with volume pricing, cloud-hosted subscriptions, strategic research collaborations with BMS, Sanofi, and Takeda, dedicated scientific support teams, and academic/government licensing programs
CLIA-certified genomics laboratory, CAP accredited, HIPAA compliant, SOC 2 Type II, de-identified patient data network of 7M+ records, EHR integration via HL7/FHIR, biopharma licensing agreements, and enterprise analytics platform with dedicated clinical account management
Core Categories
AI Healthcare ToolsAI Research & Education Tools
AI Healthcare ToolsAI Research & Education Tools
Physics-based molecular simulation: Maestro, Glide, Jaguar, Prime, and FEP+ for drug and materials discovery
Difference
Schrödinger Advantage
Not listed
Bunsen AI co-scientist (July 2026) for hypothesis generation, experiment design, and molecular insight
Difference
Schrödinger Advantage
Not listed
FEP+ for industry-leading binding affinity prediction in lead optimization
Difference
Schrödinger Advantage
Not listed
Structure-based drug design, ADMET prediction, and quantum chemistry in one platform
Difference
Schrödinger Advantage
Not listed
Cloud-hosted software subscriptions with 10-15% ACV growth target for 2026
Difference
Schrödinger Advantage
Not listed
Drug discovery pipeline with BMS, Sanofi, and Takeda — FY26 guidance raised to $65-75M
Supported
Supported
Materials science applications: battery design, semiconductors, and specialty chemicals
Difference
Schrödinger Advantage
Not listed
$255.87M revenue in 2025 with 23% growth — NASDAQ listed (SDGR)
Difference
Schrödinger Advantage
Not listed
500+ enterprise customers including top 20 global pharma companies
Difference
Schrödinger Advantage
Not listed
Founded 1990 by Professor Richard Friesner — 34+ years of computational chemistry leadership
Difference
Schrödinger Advantage
Not listed
Comprehensive genomic profiling — solid tumor (xT), germline (xG), RNA (xR), liquid biopsy (xF), and expression (xE) testing
Difference
Not listed
Tempus AI Advantage
Multimodal data platform with 7M+ de-identified patient records across clinical, molecular, and imaging data
Difference
Not listed
Tempus AI Advantage
AI-powered clinical trial matching (TIME Trial) to improve enrollment rates and identify eligible patients
Difference
Not listed
Tempus AI Advantage
Tempus One — AI clinical assistant for real-time treatment insights and literature synthesis at point of care
Difference
Not listed
Tempus AI Advantage
Neuropsychiatry panel for pharmacogenomics and psychiatric medication response prediction
Difference
Not listed
Tempus AI Advantage
Cardiology ECG analysis AI for arrhythmia and cardiac condition detection
Difference
Not listed
Tempus AI Advantage
Algos platform for population health analytics across health system patient cohorts
Difference
Not listed
Tempus AI Advantage
CLIA-certified lab with CAP accreditation for clinical-grade genomic report delivery
Difference
Not listed
Tempus AI Advantage
Publicly traded (NASDAQ: TEM) — founded 2015, 3,800+ employees, $8.79B total raised
Difference
Not listed
Tempus AI Advantage
Schrödinger icon

Schrödinger Pros & Cons

Pros

  • 34+ years of computational chemistry leadership — most trusted physics-based platform in pharma
  • Bunsen AI co-scientist launched July 2026 — BMS immediately deployed it
  • FEP+ delivers industry-leading accuracy in binding affinity prediction
  • NASDAQ SDGR — $255.87M revenue in 2025, 23% growth, turning profitable in Q2 2026
  • 500+ pharma enterprise customers including BMS, Sanofi, Takeda, Pfizer, and Eli Lilly
  • Materials science applications extend reach to battery, semiconductor, and chemical sectors
  • Cloud-hosted subscriptions eliminate on-premise infrastructure burden

Cons

  • Software is expensive — enterprise pricing puts it out of reach for smaller labs
  • Stock (SDGR) has been under pressure — market cap ~$1B despite strong platform
  • Drug discovery segment revenue is milestone-dependent and lumpy
  • Platform learning curve is steep without computational chemistry background
  • Competition from newer, purely AI-native platforms is intensifying
Tempus AI icon

Tempus AI Pros & Cons

Pros

  • Publicly traded (NASDAQ: TEM) — one of the most credible precision medicine AI companies
  • 7M+ de-identified patient records — one of the world's largest clinical-molecular datasets
  • Comprehensive genomic testing across 6 test types covering all major oncology applications
  • Tempus One AI provides real-time clinical insights at the point of care
  • TIME Trial dramatically improves clinical trial matching and enrollment rates
  • 3,800+ employees and $8.79B total capital raised since founding
  • Expanding beyond oncology into neuropsychiatry, cardiology, and infectious disease

Cons

  • Enterprise and institutional pricing — not accessible to individual clinicians or small practices
  • Focused primarily on oncology and genomics — not a general-purpose clinical AI tool
  • Genomic test turnaround requires laboratory processing time
  • Data platform access and licensing requires formal agreements
  • Some AI insights require institutional genomic data infrastructure to fully leverage
Head-to-Head Battle Cards

Popular Comparisons

Direct feature matrices, pricing breakdowns, and real-world benchmark duels

All AI Healthcare Tools comparisons
Tempus AI vs Insilico Medicine Comparison Battle Card - Features, Pricing & Review in AI Healthcare Tools
Direct head-to-head AI tool comparison between Tempus AI and Insilico Medicine in AI Healthcare Tools featuring side-by-side feature matrix, pricing tiers, and benchmark verdict.
AI Healthcare ToolsCompare
Tempus AI vs Atomwise Comparison Battle Card - Features, Pricing & Review in AI Healthcare Tools
Direct head-to-head AI tool comparison between Tempus AI and Atomwise in AI Healthcare Tools featuring side-by-side feature matrix, pricing tiers, and benchmark verdict.
AI Healthcare ToolsCompare
Schrödinger vs Atomwise Comparison Battle Card - Features, Pricing & Review in AI Healthcare Tools
Direct head-to-head AI tool comparison between Schrödinger and Atomwise in AI Healthcare Tools featuring side-by-side feature matrix, pricing tiers, and benchmark verdict.
AI Healthcare ToolsCompare
Tempus AI vs Nabla Comparison Battle Card - Features, Pricing & Review in AI Healthcare Tools
Direct head-to-head AI tool comparison between Tempus AI and Nabla in AI Healthcare Tools featuring side-by-side feature matrix, pricing tiers, and benchmark verdict.
AI Healthcare ToolsCompare